Myocardial Characterization on CT: Late Iodine Enhancement and Extracellular Volume
Axel Bartoli
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Radiology, TIMONE Hospital, AP-HM, Marseille, France
CRMBM – UMR CNRS 7339, Aix-Marseille University, Marseille, France
Search for more papers by this authorChiara Gnasso
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorCorresponding Author
Anna Palmisano
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Correspondence: Anna Palmisano ([email protected])
Search for more papers by this authorAndrea Bettinelli
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorDavide Vignale
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorAntonio Esposito
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorAxel Bartoli
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Radiology, TIMONE Hospital, AP-HM, Marseille, France
CRMBM – UMR CNRS 7339, Aix-Marseille University, Marseille, France
Search for more papers by this authorChiara Gnasso
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorCorresponding Author
Anna Palmisano
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Correspondence: Anna Palmisano ([email protected])
Search for more papers by this authorAndrea Bettinelli
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorDavide Vignale
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorAntonio Esposito
Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy
Search for more papers by this authorAxel Bartoli and Chiara Gnasso equally contributed to this study.
ABSTRACT
Myocardial tissue characterization is fundamental in diagnosing, treating, and managing various cardiac diseases. In recent years, cardiac computed tomography (CCT) emerged as a valuable alternative to cardiac magnetic resonance (CMR) for myocardial tissue characterization, with the possibility to detect myocardial scar and quantify the extracellular volume fraction in a single CT study with the advantage of combined coronary arteries evaluation, shorter scanning time, and less susceptibility to device artifacts compared to CMR. However, CCT is typically affected by a lower contrast-to-noise ratio and potentially increased radiation exposure. Therefore, a deep understanding of the available technology and the strategies for acquisition optimization is of fundamental importance to improve image quality and accuracy, while minimizing radiation exposure. This review summarizes principles of myocardial characterization on CCT, acquisition protocols according to the different technologies available including the dual-energy CT and the innovative photon-counting detector CT, and setting of clinical utility.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- 1N. G. Frangogiannis, “Cardiac Fibrosis,” Cardiovascular Research 117 (2021): 1450–1488.
- 2X. Yin, X. Yin, and X. Pan, “Post-Myocardial Infarction Fibrosis: Pathophysiology, Examination, and Intervention,” Frontiers in Pharmacology 14 (2023): 1070973, https://doi.org/10.3389/fphar.2023.1070973.
- 3A. Bertaud, A. Joshkon, X. Heim, et al., “Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis,” International Journal of Molecular Sciences 24 (2023): 1756.
- 4R. Khedraki, A. A. Robinson, T. Jordan, J. L. Grodin, and R. C. Mohan, “A Review of Current and Evolving Imaging Techniques in Cardiac Amyloidosis,” Current Treatment Options in Cardiovascular Medicine 25 (2023): 43–63.
- 5T. D. Karamitsos, A. Arvanitaki, H. Karvounis, S. Neubauer, and V. M. Ferreira, “Myocardial Tissue Characterization and Fibrosis by Imaging,” JACC: Cardiovascular Imaging 13 (2020): 1221–1234.
- 6A. Esposito, A. Palmisano, and S. Antunes, “Cardiac CT With Delayed Enhancement in the Characterization of Ventricular Tachycardia Structural Substrate Relationship Between CT-Segmented Scar and Electro-Anatomic Mapping,” JACC: Cardiovascular Imaging 9, no. 7 (2016): 822–832.
- 7D. Vignale, A. Palmisano, C. Colantoni, et al., “Toward a One-Stop Shop CT Protocol in Acute Chest Pain Syndrome,” Radiology 306 (2023): E3–E4.
- 8B. L. Gerber, B. Belge, G. J. Legros, et al., “Characterization of Acute and Chronic Myocardial Infarcts by Multidetector Computed Tomography,” Circulation 113 (2006): 823–833.
- 9Y. Kurobe, K. Kitagawa, and T. Ito, “Myocardial Delayed Enhancement With Dual-Source CT: Advantages of Targeted Spatial Frequency Filtration and Image Averaging Over Half-Scan Reconstruction,” Journal of Cardiovascular Computed Tomography 8 (2014): 289–298.
- 10A. Hamdy, K. Kitagawa, Y. Goto, et al., “Comparison of the Different Imaging Time Points in Delayed Phase Cardiac CT for Myocardial Scar Assessment and Extracellular Volume Fraction Estimation in Patients With Old Myocardial Infarction,” The International Journal of Cardiovascular Imaging 35 (2019): 917–926.
- 11M. van Assen, M. Vonder, G. J. Pelgrim, P. L. Von Knebel Doeberitz, and R. Vliegenthart, “Computed Tomography for Myocardial Characterization in Ischemic Heart Disease: A State-of-the-Art Review,” European Radiology Experimental 4 (2020): 36.
- 12A. H. Mahnken, P. Bruners, G. Mühlenbruch, et al., “Low Tube Voltage Improves Computed Tomography Imaging of Delayed Myocardial Contrast Enhancement in an Experimental Acute Myocardial Infarction Model,” Investigative Radiology 42, no. 2 (2007): 123–129.
- 13A. Palmisano, D. Vignale, G. Benedetti, A. Del Maschio, F. De Cobelli, and A. Esposito, “Late Iodine Enhancement Cardiac Computed Tomography for Detection of Myocardial Scars: Impact of Experience in the Clinical Practice,” La Radiologia Medica 125 (2020): 128–136.
- 14T. Flohr and B. Schmidt, “Technical Basics and Clinical Benefits of Photon-Counting CT,” Investigative Radiology 58, no. 7 (2023): 441–450, https://doi.org/10.1097/RLI.0000000000000980.
- 15S. Oda, T. Emoto, and T. Nakaura, “Myocardial Late Iodine Enhancement and Extracellular Volume Quantification With Dual-Layer Spectral Detector Dual-Energy Cardiac CT,” Radiology: Cardiothoracic Imaging 1 (2019): e180003.
- 16P. Liu, L. Lin, C. Xu, et al., “Quantitative Analysis of Late Iodine Enhancement Using Dual-Layer Spectral Detector Computed Tomography: Comparison With Magnetic Resonance Imaging,” Quantitative Imaging in Medicine and Surgery 12 (2022): 310–320.
- 17S. Chang, K. Han, and J.-C. Youn, “Utility of Dual-Energy CT-Based Monochromatic Imaging in the Assessment of Myocardial Delayed Enhancement in Patients With Cardiomyopathy,” Radiology 287 (2018): 442–451.
- 18N. Oyama-Manabe, S. Oda, Y. Ohta, H. Takagi, K. Kitagawa, and M. Jinzaki, “Myocardial Late Enhancement and Extracellular Volume With Single-Energy, Dual-Energy, and Photon-Counting Computed Tomography,” Journal of Cardiovascular Computed Tomography 18 (2024): 3–10.
- 19J. L. Cavalcante and H. Koike, “The Rise of Myocardial Extracellular Volume Fraction in Computed Tomography for Identification of Cardiac Amyloidosis,” JACC: Cardiovascular Imaging 15 (2022): 2095–2097.
- 20G. J. Aquino, J. O'Doherty, and U. J. Schoepf, “Myocardial Characterization With Extracellular Volume Mapping With a First-Generation Photon-Counting Detector CT With MRI Reference,” Radiology 307, no. 2 (2023): e222030, https://doi.org/10.1148/radiol.222030.
- 21N. Y. Kim, D. J. Im, J.-C. Youn, et al., “Synthetic Extracellular Volume Fraction Derived Using Virtual Unenhanced Attenuation of Blood on Contrast-Enhanced Cardiac Dual-Energy CT in Nonischemic Cardiomyopathy,” American Journal of Roentgenology 218 (2022): 454–461.
- 22V. Mergen, T. Sartoretti, and E. Klotz, “Extracellular Volume Quantification With Cardiac Late Enhancement Scanning Using Dual-Source Photon-Counting Detector CT,” Investigative Radiology 57 (2022): 406–411.
- 23P. R. Scully, K. P. Patel, and B. Saberwal, “Identifying Cardiac Amyloid in Aortic Stenosis,” JACC: Cardiovascular Imaging 13 (2020): 2177–2189.
- 24M. S. Nacif, N. Kawel, J. J. Lee, et al., “Interstitial Myocardial Fibrosis Assessed as Extracellular Volume Fraction With Low-Radiation-Dose Cardiac CT,” Radiology 264 (2012): 876–883.
- 25G. Cundari, N. Galea, V. Mergen, H. Alkadhi, and M. Eberhard, “Myocardial Extracellular Volume Quantification With Computed Tomography – Current Status and Future Outlook,” Insights Imaging 14, no. 1 (2023): 156, https://doi.org/10.1186/s13244-023-01506-6.
- 26R. G. Muthalaly, S. Tan, A. J. Nelson, et al., “Variation of Computed Tomography-Derived Extracellular Volume Fraction and the Impact of Protocol Parameters: A Systematic Review and Meta-Analysis,” Journal of Cardiovascular Computed Tomography 18 (2024): 457–464.
- 27P. C. Douek, S. Boccalini, E. H. G. Oei, et al., “Clinical Applications of Photon-Counting CT: A Review of Pioneer Studies and a Glimpse Into the Future,” Radiology 309 (2023): e222432, https://doi.org/10.1148/radiol.222432.
- 28A. Esquivel, A. Ferrero, A. Mileto, et al., “Photon-Counting Detector CT: Key Points Radiologists Should Know,” Korean Journal of Radiology 23 (2022): 854.
- 29R. Booij, N. R. van der Werf, M. L. Dijkshoorn, A. van der Lugt, and M. van Straten, “Assessment of Iodine Contrast-To-Noise Ratio in Virtual Monoenergetic Images Reconstructed From Dual-Source Energy-Integrating CT and Photon-Counting CT Data,” Diagnostics 12 (2022): 1467.
- 30C. Gnasso, D. Pinos, and U. J. Schoepf, “Impact of Reconstruction Parameters on the Accuracy of Myocardial Extracellular Volume Quantification on a First-Generation, Photon-Counting Detector CT,” European Radiology Experimental 8 (2024): 70.
- 31U. Hoffmann, F. Bamberg, and C. U. Chae, “Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain,” Journal of the American College of Cardiology 53 (2009): 1642–1650.
- 32E. Gerbaud, E. Harcaut, and P. Coste, “Cardiac Magnetic Resonance Imaging for the Diagnosis of Patients Presenting With Chest Pain, Raised Troponin, and Unobstructed Coronary Arteries,” The International Journal of Cardiovascular Imaging 28 (2012): 783–794.
- 33A. Esposito, A. Palmisano, and M. Barbera, “Cardiac Computed Tomography in Troponin-Positive Chest Pain,” JACC: Cardiovascular Imaging 12 (2019): 745–748.
- 34C. Bouleti, G. Baudry, and B. Iung, “Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis,” JACC: Cardiovascular Imaging 10 (2017): 826–827.
- 35G. Pontone, A. Baggiano, and E. Conte, ““Quadruple Rule-Out” with Computed Tomography in a COVID-19 Patient with Equivocal Acute Coronary Syndrome Presentation,” JACC: Cardiovascular Imaging 13 (2020): 1854–1856.
- 36Y. Ohta, S. Kitao, H. Yunaga, et al., “Myocardial Delayed Enhancement CT for the Evaluation of Heart Failure: Comparison to MRI,” Radiology 288 (2018): 682–691.
- 37A. Baggiano, E. Conte, and L. Spiritigliozzi, “Quantification of Extracellular Volume With Cardiac Computed Tomography in Patients With Dilated Cardiomyopathy,” Journal of Cardiovascular Computed Tomography 17 (2023): 261–268.
- 38S. Yashima, H. Takaoka, and T. Iwahana, “Evaluation of Extracellular Volume by Computed Tomography Is Useful for Prediction of Prognosis in Dilated Cardiomyopathy,” Heart and Vessels 38 (2023): 185–194.
- 39C. B. Monti, M. Zanardo, T. Bosetti, et al., “Assessment of Myocardial Extracellular Volume on Body Computed Tomography in Breast Cancer Patients Treated With Anthracyclines,” Quantitative Imaging in Medicine and Surgery 10 (2020): 934–944.
- 40T. Wang, B. Ouyang, L. Tang, L. Li, and Y. Liu, “Myocardial Extracellular Volume Derived From Contrast-Enhanced Chest Computed Tomography in Longitudinal Evaluation of Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors,” Quantitative Imaging in Medicine and Surgery 14 (2024): 3107–3120.
- 41M. Habis, A. Capderou, S. Ghostine, et al., “Acute Myocardial Infarction Early Viability Assessment by 64-Slice Computed Tomography Immediately after Coronary Angiography,” Journal of the American College of Cardiology 49 (2007): 1178–1185.
- 42H. Watabe, A. Sato, and H. Nishina, “Enhancement Patterns Detected by Multidetector Computed Tomography Are Associated With Microvascular Obstruction and Left Ventricular Remodelling in Patients With Acute Myocardial Infarction,” European Heart Journal 37 (2016): 684–692.
- 43A. Sato, T. Nozato, and H. Hikita, “Prognostic Value of Myocardial Contrast Delayed Enhancement with 64-Slice Multidetector Computed Tomography after Acute Myocardial Infarction,” Journal of the American College of Cardiology 59 (2012): 730–738.
- 44A. H. Mahnken, P. Bruners, C. M. Bornikoel, N. Krämer, and R. W. Guenther, “Assessment of Myocardial Edema by Computed Tomography in Myocardial Infarction,” JACC: Cardiovascular Imaging 2 (2009): 1167–1174.
- 45N. Bettencourt, N. D. Ferreira, and D. Leite, “CAD Detection in Patients with Intermediate-High Pre-Test Probability,” JACC: Cardiovascular Imaging 6 (2013): 1062–1071.
- 46B. Jáuregui, D. Soto-Iglesias, and G. Zucchelli, “Arrhythmogenic Substrate Detection in Chronic Ischaemic Patients Undergoing Ventricular Tachycardia Ablation Using Multidetector Cardiac Computed Tomography: Compared Evaluation With Cardiac Magnetic Resonance,” EP Europace 23 (2021): 82–90.
- 47J. L. Wichmann, R. W. Bauer, M. Doss, et al., “Diagnostic Accuracy of Late Iodine–Enhancement Dual-Energy Computed Tomography for the Detection of Chronic Myocardial Infarction Compared with Late Gadolinium–Enhancement 3-T Magnetic Resonance Imaging,” Investigative Radiology 48 (2013): 851–856.
- 48E. Arbelo, A. Protonotarios, and J. R. Gimeno, “2023 ESC Guidelines for the Management of Cardiomyopathies,” European Heart Journal 44 (2023): 3503–3626.
- 49S. R. Ommen, S. Mital, and M. A. Burke, “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: Executive Summary,” Circulation 142, no. 25 (2020): e533–e557, https://doi.org/10.1161/CIR.0000000000000938.
- 50L. Zhao, X. Ma, G. M. Feuchtner, C. Zhang, and Z. Fan, “Quantification of Myocardial Delayed Enhancement and Wall Thickness in Hypertrophic Cardiomyopathy: Multidetector Computed Tomography Versus Magnetic Resonance Imaging,” European Journal of Radiology 83 (2014): 1778–1785.
- 51A. A. Shiozaki, T. Senra, and E. Arteaga, “Myocardial Fibrosis Detected by Cardiac CT Predicts Ventricular Fibrillation/Ventricular Tachycardia Events in Patients With Hypertrophic Cardiomyopathy,” Journal of Cardiovascular Computed Tomography 7 (2013): 173–181.
- 52T. Nishihara, T. Miyoshi, N. Akagi, M. Nakashima, K. Nakamura, and H. Ito, “Myocardial Late Iodine Enhancement Using Photon-Counting Computed Tomography in Patients With Hypertrophic Cardiomyopathy,” Circulation Reports 5 (2023): 269–270.
- 53H.-J. Lee, D. J. Im, J.-C. Youn, et al., “Myocardial Extracellular Volume Fraction With Dual-Energy Equilibrium Contrast-Enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison With Cardiac MR Imaging,” Radiology 280 (2016): 49–57.
- 54T. A. Treibel, S. Bandula, and M. Fontana, “Extracellular Volume Quantification by Dynamic Equilibrium Cardiac Computed Tomography in Cardiac Amyloidosis,” Journal of Cardiovascular Computed Tomography 9 (2015): 585–592.
- 55A. Tavoosi, J. B. O. de Brito, H. El Mais, et al., “Dual Versus Single Energy Cardiac CT to Measure Extracellular Volume in Cardiac Amyloidosis: Correlations With Cardiac MRI,” IJC Heart & Vasculature 44 (2023): 101166.
- 56F. Gama, S. Rosmini, and S. Bandula, “Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients with Cardiac Amyloidosis,” JACC Cardiovascular Imaging 15 (2022): 2082–2094.
- 57J. Marek, K. Bayerová, P. Kuchynka, V. Černý, and A. Linhart, “A Unique Case of Extensive Myocardial Late Iodine Enhancement on CT in Anderson-Fabry Disease,” European Heart Journal – Cardiovascular Imaging 24 (2023): e63–e63.
- 58C. F. Azevedo, M. Nigri, M. L. Higuchi, et al., “Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease,” Journal of the American College of Cardiology 56 (2010): 278–287.
- 59D. Vignale, A. Palmisano, and C. Gnasso, “Extracellular Volume Fraction (ECV) Derived From Pre-operative Computed Tomography Predicts Prognosis in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI),” European Heart Journal – Cardiovascular Imaging 24 (2023): 887–896.
- 60M. Suzuki, T. Toba, and Y. Izawa, “Prognostic Impact of Myocardial Extracellular Volume Fraction Assessment Using Dual-Energy Computed Tomography in Patients Treated with Aortic Valve Replacement for Severe Aortic Stenosis,” Journal of the American Heart Association 10, no. 18 (2021): e020655, https://doi.org/10.1161/JAHA.120.020655.
- 61X. He, Y. Li, Y. Wang, et al., “Prognostic Value of CT-Derived Myocardial Biomarkers: Extracellular Volume Fraction and Strain in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis,” Academic Radiology 31 (2024): 4352–4364.
- 62B. Tamarappoo, D. Han, and J. Tyler, “Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients with Low-Flow Low-Gradient Aortic Stenosis,” JACC: Cardiovascular Imaging 13 (2020): 2591–2601.
- 63K. P. Patel, P. R. Scully, and B. Saberwal, “Regional Distribution of Extracellular Volume Quantified by Cardiac CT in Aortic Stenosis: Insights into Disease Mechanisms and Impact on Outcomes,” Circulation: Cardiovascular Imaging 17 (2024): 5, https://doi.org/10.1161/CIRCIMAGING.123.015996.
- 64H. Koike, M. Fukui, and T. Treibel, “Comprehensive Myocardial Assessment by Computed Tomography,” JACC: Cardiovascular Imaging 17 (2024): 396–407.
- 65T. Nishii, T. Kobayashi, and H. Tanaka, “Deep Learning-Based Post Hoc CT Denoising for Myocardial Delayed Enhancement,” Radiology 305 (2022): 82–91.
- 66H. O'Brien, M. C. Williams, R. Rajani, and S. Niederer, “Radiomics and Machine Learning for Detecting Scar Tissue on CT Delayed Enhancement Imaging,” Frontiers in Cardiovascular Medicine 9 (2022): 847825, https://doi.org/10.3389/fcvm.2022.847825.
- 67A. Esposito, A. Palmisano, S. Antunes, et al., “Assessment of Remote Myocardium Heterogeneity in Patients With Ventricular Tachycardia Using Texture Analysis of Late Iodine Enhancement (LIE) Cardiac Computed Tomography (cCT) Images,” Molecular Imaging and Biology 20 (2018): 816–825.
- 68I. Ayx, H. Tharmaseelan, A. Hertel, et al., “Comparison Study of Myocardial Radiomics Feature Properties on Energy-Integrating and Photon-Counting Detector CT,” Diagnostics 12 (2022): 1294.
- 69G. Tremamunno, A. Varga-Szemes, U. J. Schoepf, et al., “Intraindividual Reproducibility of Myocardial Radiomic Features Between Energy-Integrating Detector and Photon-Counting Detector CT Angiography,” European Radiology Experimental 8 (2024): 101.
- 70A. H. Mahnken, R. Koos, M. Katoh, et al., “Assessment of Myocardial Viability in Reperfused Acute Myocardial Infarction Using 16-Slice Computed Tomography in Comparison to Magnetic Resonance Imaging,” Journal of the American College of Cardiology 45 (2005): 2042–2047.
- 71H. M. Gweon, S. J. Kim, T. H. Kim, et al., “Evaluation of Reperfused Myocardial Infarction by Low-Dose Multidetector Computed Tomography Using Prospective Electrocardiography (ECG)-Triggering: Comparison With Magnetic Resonance Imaging,” Yonsei Medical Journal 51 (2010): 683.
- 72R. Goetti, G. Feuchtner, P. Stolzmann, et al., “Delayed Enhancement Imaging of Myocardial Viability: Low-Dose High-Pitch CT Versus MRI,” European Radiology 21 (2011): 2091–2099.
- 73J.-F. Deux, C.-I. Mihalache, F. Legou, et al., “Noninvasive Detection of Cardiac Amyloidosis Using Delayed Enhanced MDCT: A Pilot Study,” European Radiology 25 (2015): 2291–2297.
- 74T. Aikawa, N. Oyama-Manabe, and M. Naya, “Delayed Contrast-Enhanced Computed Tomography in Patients With Known or Suspected Cardiac Sarcoidosis: A Feasibility Study,” European Radiology 27 (2017): 4054–4063.
- 75A. Palmisano, D. Vignale, and M. Tadic, “Myocardial Late Contrast Enhancement CT in TroponinPositive Acute Chest Pain Syndrome,” Radiology 302 (2022): 545–553.
- 76N. Y. Kim, D. J. Im, Y. J. Hong, et al., “Feasibility of the Threshold-Based Quantification of Myocardial Fibrosis on Cardiac CT as a Prognostic Marker in Nonischemic Dilated Cardiomyopathy,” Korean Journal of Radiology 25 (2024): 540.
- 77S. Bandula, S. K. White, A. S. Flett, et al., “Measurement of Myocardial Extracellular Volume Fraction by Using Equilibrium Contrast-Enhanced CT: Validation Against Histologic Findings,” Radiology 269 (2013): 396–403.
- 78Y. Ohta, J. Kishimoto, S. Kitao, et al., “Investigation of Myocardial Extracellular Volume Fraction in Heart Failure Patients Using Iodine Map With Rapid-kV Switching Dual-Energy CT: Segmental Comparison With MRI T1 Mapping,” Journal of Cardiovascular Computed Tomography 14 (2020): 349–355.
- 79R. Wang, X. Liu, U. J. Schoepf, et al., “Extracellular Volume Quantitation Using Dual-Energy CT in Patients With Heart Failure: Comparison With 3T Cardiac MR,” International Journal of Cardiology 268 (2018): 236–240.
- 80S. A. Si-Mohamed, L. M. Restier, A. Branchu, et al., “Diagnostic Performance of Extracellular Volume Quantified by Dual-Layer Dual-Energy CT for Detection of Acute Myocarditis,” Journal of Clinical Medicine 10 (2021): 3286.
- 81J.-F. Deux, R. Nouri, and V. Tacher, “Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis,” Radiology 300 (2021): 326–335.
- 82B. Dubourg, J.-N. Dacher, E. Durand, et al., “Single-Source Dual Energy CT to Assess Myocardial Extracellular Volume Fraction in Aortic Stenosis Before Transcatheter Aortic Valve Implantation (TAVI),” Diagnostic and Interventional Imaging 102 (2021): 561–570.
- 83R.-X. Qi, J. Shao, J.-S. Jiang, et al., “Myocardial Extracellular Volume Fraction Quantitation Using Cardiac Dual-Energy CT With Late Iodine Enhancement in Patients With Heart Failure Without Coronary Artery Disease: A Single-Center Prospective Study,” European Journal of Radiology 140 (2021): 109743.
- 84H. Hayashi, S. Oda, and T. Emoto, “Myocardial Extracellular Volume Quantification by Cardiac CT in Pulmonary Hypertension: Comparison With Cardiac MRI,” European Journal of Radiology 153 (2022): 110386.
- 85M. Chiocchi, M. Cerocchi, and F. Di Tosto, “Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab,” Journal of Personalized Medicine 13 (2023): 199.
- 86H. Hayashi, S. Oda, and M. Kidoh, “Myocardial Extracellular Volume Quantification in Cardiac Amyloidosis: A Comparative Study Between Cardiac Computed Tomography and Magnetic Resonance Imaging,” European Radiology 34 (2023): 1016–1025.
- 87M. Takahashi, H. Takaoka, S. Yashima, et al., “Extracellular Volume Fraction by Computed Tomography Predicts Prognosis After Transcatheter Aortic Valve Replacement,” Circulation Journal 88 (2024): 492–500.
- 88Y. Jiang, J. Ye, and Y. Yang, “Prognostic Value of Measurement of Myocardial Extracellular Volume Using Dual-Energy CT in Heart Failure With Preserved Ejection Fraction,” Scientific Reports 14 (2024): 7504.